Streetbeat News

Analyst Ratings

CYTK

HC Wainwright & Co. analyst Joseph Pantginis has reiterated a 'Buy' rating on Cytokinetics (NASDAQ:CYTK) and maintained a price target of $58.

Portfolio Pulse from Benzinga Newsdesk

November 01, 2023 | 11:01 am

APRE

HC Wainwright & Co. analyst Joseph Pantginis has reiterated a 'Buy' rating on Aprea Therapeutics (NASDAQ:APRE) and maintained a $20 price target.

Portfolio Pulse from Benzinga Newsdesk

November 01, 2023 | 10:59 am

TREE

Needham analyst Mayank Tandon has maintained a 'Buy' rating on LendingTree (NASDAQ:TREE) but lowered the price target from $27 to $17.

Portfolio Pulse from Benzinga Newsdesk

November 01, 2023 | 10:53 am

FRSH

Needham analyst Scott Berg has reiterated a 'Buy' rating on Freshworks (NASDAQ:FRSH) and maintained a price target of $25.

Portfolio Pulse from Benzinga Newsdesk

November 01, 2023 | 10:51 am

GOOG

META

AI experts Geoffrey Hinton and Yann LeCun, both known as 'Godfathers of AI', engaged in a debate on the risks of AI. Hinton, who left Google (NASDAQ:GOOG) (NASDAQ:GOOGL) to freely discuss the risks of AI, mocked LeCun's comments about open source AI, comparing it to open sourcing nuclear weapons. LeCun, who works for Meta Platforms Inc. (NASDAQ:META), defended AI's purpose to enhance human intelligence. The debate comes amid calls for AI regulation from tech leaders and the establishment of the US AI Safety Institute.

Portfolio Pulse from Rounak Jain

November 01, 2023 | 10:47 am

CGNX

Needham analyst James Ricchiuti has maintained a 'Buy' rating on Cognex (NASDAQ:CGNX) but lowered the price target from $55 to $46.

Portfolio Pulse from Benzinga Newsdesk

November 01, 2023 | 10:47 am

SSTK

Needham analyst Bernie McTernan has maintained a 'Buy' rating on Shutterstock (NYSE:SSTK) but lowered the price target from $76 to $60.

Portfolio Pulse from Benzinga Newsdesk

November 01, 2023 | 10:44 am

PRO

Needham analyst Scott Berg has reiterated a 'Buy' rating on Pros Holdings (NYSE:PRO) and maintained a price target of $40.

Portfolio Pulse from Benzinga Newsdesk

November 01, 2023 | 10:42 am

AMD

Advanced Micro Devices, Inc. (AMD) shares fell nearly 2% in premarket trading after a lukewarm Q4 outlook. Despite reporting above-consensus Q3 earnings and revenue, the company's Q4 revenue guidance of $6.1 billion trailed most analysts' estimates. KeyBanc Capital Markets analyst John Vinh trimmed the price target for AMD shares from $160 to $140, maintaining an Overweight rating.

Portfolio Pulse from Shanthi Rexaline

November 01, 2023 | 10:40 am

MYE

Myers Indus (NYSE:MYE) reported Q3 earnings of $0.38 per share, missing the analyst consensus estimate of $0.43 by 11.63%. The company also reported quarterly sales of $197.80 million, missing the analyst consensus estimate of $220.74 million by 10.39%. This represents a decrease in earnings and sales compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

November 01, 2023 | 10:37 am